Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
Deonna M AckermannAmelia K SmitMonika JandaCathelijne H van KemenadeMbathio DiengRachael L MortonRobin M TurnerAnne E CustLes IrwigJolyn K HerschPascale GuiteraH Peter SoyerVictoria MarRobyn P M SawDonald LowCynthia LowDorothy DrabarekDavid EspinozaJon EmeryPeter MurchieJohn F ThompsonRichard A ScolyerAnthony AzziAlister LilleymanKaty J L BellPublished in: Trials (2021)
Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000176864 . Registered on 18 February 2021.